Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants
Authors
Keywords
-
Journal
European Journal of Preventive Cardiology
Volume 23, Issue 5, Pages 502-510
Publisher
SAGE Publications
Online
2015-05-09
DOI
10.1177/2047487315586094
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pulmonary arterial hypertension and sepsis: Prothrombotic profile and inflammation can changes pulmonary mechanics?
- (2014) Karla Mette Waldrich Tauil et al. MEDICAL HYPOTHESES
- Association Between MTHFR Polymorphisms and Congenital Heart Disease: A Meta-analysis based on 9,329 cases and 15,076 controls
- (2014) Chao Xuan et al. Scientific Reports
- PTPN22Gene Polymorphism (C1858T) Is Associated with Susceptibility to Type 1 Diabetes: A Meta-Analysis of 19,495 Cases and 25,341 Controls
- (2013) Chao Xuan et al. ANNALS OF HUMAN GENETICS
- Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study
- (2013) Olga Kruszelnicka et al. Cardiovascular Diabetology
- Diagnostic Accuracy of Glycosylated Hemoglobin in Chinese Patients with Gestational Diabetes Mellitus: A Meta-Analysis Based on 2,812 Patients and 5,918 Controls
- (2013) Qing-Wu Tian et al. Genetic Testing and Molecular Biomarkers
- High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease
- (2012) B. V. Djordjević et al. AMINO ACIDS
- Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine–induced injury in human internal thoracic artery
- (2012) Chao Xuan et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow
- (2012) Habil Yucel et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Endothelial microparticles: missing link in endothelial dysfunction?
- (2012) Pearly JA Yong et al. European Journal of Preventive Cardiology
- Association Between Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR) C677T and Risk of Myocardial Infarction: A Meta-analysis for 8,140 Cases and 10,522 Controls
- (2011) Chao Xuan et al. ARCHIVES OF MEDICAL RESEARCH
- Serum levels of arginase I are associated with left ventricular function after myocardial infarction
- (2011) Seldag Bekpinar et al. CLINICAL BIOCHEMISTRY
- Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis
- (2011) Chao Xuan et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: A meta-analysis from 5472 cases and 4727 controls
- (2011) Chao Xuan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine andl-arginine in coronary artery disease
- (2010) Mohamed Z. Gad et al. BIOMARKERS
- Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease
- (2010) Tevfik Aktoz et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Association between Asymmetric Dimethylarginine and Neopterin in Patients with and without Angiographic Coronary Artery Disease
- (2009) C. Murr et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started